US 10,874,677 K1 (3,504th)
	Subcutaneously administered anti-IL-6 receptor antibody
Xiaoping Zhang; and Kimio Terao
Filed by Hoffmann-La Roche Inc.; and CHUGAI SEIYAKU KABUSHIKI KAISHA
Assigned to Hoffmann-La Roche Inc.; and CHUGAI SEIYAKU KABUSHIKI KAISHA
Trial No. IPR2022-00579, Feb. 21, 2022
Inter Partes Review Certificate for Patent 10,874,677, issued Dec. 29, 2020, Appl. No. 16/254,105, Jan. 22, 2019
Inter Partes Review Certificate issued Mar. 19, 2024